Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates

Infection and Immunity

Volumn 65, Issue 4, 1997, Pages 1189-1195

  Rhoades, Elizabeth R ^a   Orme, Tan M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CELL FREE SYSTEM; CELL KILLING; CELL VIABILITY; MYCOBACTERIUM TUBERCULOSIS; PHAGOSOME; PRIORITY JOURNAL;

EID: 0030988521     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.4.1189-1195.1997     Document Type: Article

References (56)

1. Adams, L. B., S. G. Franzblau, Z. Vavrin, J. B. Hibbs, Jr., and J. L. Krahenbuhl. 1991. L-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J. Immunol. 147:1642-1646.
2. Adams, L. B., J. B. Hibbs, Jr., R. R. Taintor, and J. L. Krahenbuhl. 1990. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:2725-2729.
3. Anthony, L. S. D., P. J. Morrissey, and F. E. Nano. 1992. Growth inhibition of Francisella tularensis live vaccine strain by IFN-γ-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J. Immunol. 148:1829-1834.
4. Appelberg, R., and I. M. Orme. 1993. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murinc macrophages. Immunology 80:352-359.
5. Armstrong, J. A., and P. D. A. Hart. 1971. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med. 134:713-740.
6. Bermudez, L. E. 1993. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin. Exp. Immunol. 91:277-281.
7. Bermudez, L. E., and L. S. Young. 1990. Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex. J. Leukocyte Biol. 48:67-73.
8. Bermudez, L. E., and L. S. Young. 1988. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140:3006-3013.
9. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
10. Cooper, A. M. 1995. The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol. 7:512-516.
11. Crowle, A. J., R. Dahl, E. Ross, and M. H. May. 1991. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect. Immun. 59:1823-1831.
12. Deng, W., B. Thiel, C. S. Tannenbaum, T. A. Hamilton, and D. J. Stuehr. 1993. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. J. Immunol. 151:322-329.
13. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132:150-157.
14. Denis, M. 1991. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49:380-387.
15. Doi, T., M. Ando, T. Akaike, M. Suga, K. Sato, and H. Maeda. 1993. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect. Immun. 61:1980-1989.
16. Douvas, G. S., D. L. Looker, A. E. Vatter, and A. J. Crowle. 1985. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun. 50:1-8.
17. Farrell, A. J., and D. R. Blake. 1996. Nitric oxide. Ann. Rheum. Dis. 55:7-20.
18. Flesch, I., J. Hess, I. Oswald, and S. Kaufmann. 1994. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int. Immunol. 6:693-700.
19. Flesch, I., and S. H. E. Kaufmann. 1987. Mycobacterial growth inhibition by interferon-γ-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138:4408-4413.
20. Flesch, I. E. A., and S. H. Kaufmann. 1988. Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages. Infect. Immun. 56:1464-1469.
21. Flesch, I. E. A., and S. H. E. Kaufmann. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218.
22. Frehel, C., C. DeChastellier, T. Lang, and N. Rastogi. 1986. Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect. Immun. 52:252-262.
23. Goren, M. B., J. M. Grange, V. R. Aber, B. W. Allen, and D. A. Mitchison. 1982. Role of lipid content and hydrogen peroxide susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis. Br. J. Exp. Pathol. 63:693-700.
24. Green, S. J., C. A. Nacy, and M. S. Meltzer. 1991. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J. Leukocyte Biol. 50:90-103.
25. Green, S. J., L. F. Scheller, M. A. Marletta, M. C. Seguin, F. W. Klotz, M. Slayter, B. J. Nelson, and C. A. Nacy. 1994. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol. Lett. 43:87-94.
26. Hart, P. D. A., and J. A. Armstrong. 1974. Strain virulence and the lysosomal response in macrophages infected with Mycobacterium tuberculosis. Infect. Immun. 10:742-746.
27. Jackett, P. S., V. R. Aber, and D. B. Lowrie. 1978. Virulence and resistance to Superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J. Gen. Microbiol. 104:37-45.
28. King, P. A., E. Jamison, D. Strahs, V. E. Anderson, and M. Brenowitz. 1993. 'Footprinting' proteins on DNA with peroxonitrous acid. Nucleic Acids Res. 21:2473-2478.
29. Liew, F. Y., S. Millott, C. Parkinson, R. M. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797.
30. Marietta, M. A. 1993. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:12231-12234.
31. Mor, N., M. B. Goren, and A. J. Crowle. 1989. Enhancement of growth of Mycobacterium lepraemurium in macrophages by gamma interferon. Infect. Immun. 57:2586-2587.
32. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
33. Nathan, C., and Q.-W. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-13728.
34. Nathan, C. F., and J. B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.
35. O'Brien, L., J. Carmichael, D. B. Lowrie, and P. W. Andrew. 1994. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect. Immun. 62:5187-5190.
36. Oh, Y.-K., and R. M. Straubinger. 1996. Intracellular fate of Mycobacterium avium: use of dual-label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosomelysosome interaction. Infect. Immun. 64:319-325.
37. G-methyl-L-arginine. Biochem. Biophys. Res. Commun. 177:828-833.
38. Ordway, D. J., M. G. Sonnenberg, S. A. Donahue, J. T. Belisle, and I. M. Orme. 1995. Drug-resistant strains of Mycobacterium tuberculosis exhibit a wide range of virulence for mice. Infect. Immun. 63:741-743.
39. Orme, I. M. 1987. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J. Immunol. 138:4414-4418.
40. Orme, I. M., P. Anderson, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481-1497.
41. Orme, I. M., and F. M. Collins. 1983. Resistance of various strains of mycobacteria to killing by activated macrophages in vitro. J. Immunol. 131:1452-1454.
42. Rhoades, E. R., A. M. Cooper, and I. M. Orme. 1995. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 63:3871-3877.
43. Roach, T. I. A., C. H. Barton, D. Chatterjee, F. Y. Liew, and J. M. Blackwell. 1995. Opposing effects of interferon-γ on iNOS and interleukin-10 expression on lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology 85:106-113.
44. Rook, G. A. W., J. Steele, M. Ainsworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333-338.
45. Shank, J. L., J. H. Silliker, and R. H. Harper. 1962. The effect of nitric oxide on bacteria. Appl. Microbiol. 10:185-189.
46. Shiratsuchi, H., J. J. Johnson, H. Toba, and J. J. Ellner. 1990. Strain- and donor-related differences in the interaction of Mycobacterium avium with human monocytes and its modulation by Interferon-γ J. Infect. Dis. 162:932-938.
47. Stuehr, D. J., S. S. Gross, I. Sakuma, R. Levi, and C. F. Nathan. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011-1020.
48. Stuehr, D. J., and M. A. Marietta. 1987. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-γ. J. Immunol. 139:518-525.
49. Stuehr, D. J., and C. F. Nathan. 1989. Nitric oxide. A macrophage product responsible for the cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555.
50. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678-681.
51. Tarr, H. L. A. 1942. The action of nitrites on bacteria: further experiments. J. Fish. Res. Board Can. 6:74-89.
52. Tsukamura, M., and S. Tsukamura. 1967. Differentiation of mycobacteria by susceptibility to nitrite and propylene glycol. Am. Rev. Respir. Dis. 98:505-506.
53. Tummon, R. 1975. Growth inhibition of Mycobacterium tuberculosis by oleate in acidified medium. Med. Lab. Tech. 32:229-232.
54. Vodovotz, Y., N. S. Kwon, M. Pospischil, J. Manning, J. Paik, and C. Nathan. 1994. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial lipopolysaccharide. J. Immunol. 152:4110-4118.
55. Xie, Q.-W., R. Whisnant, and C. F. Nathan, 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
56. Yarbrough, J. M., J. B. Rake, and R. G. Eagun. 1980. Bacterial inhibitory effects of nitrite: inhibition of active transport, but not of group translocation, and of intracellular enzymes. Appl Environ. Microbiol. 39:831-834.